Primary resistance (PrR) versus acquired resistance (AcR) to immune checkpoint inhibitors (ICI) in first-line metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Guida, A. [1 ]
Silva, C. Alves Costa [2 ]
Colomba-Blameble, E. [2 ]
Flippot, R. [2 ]
Salviat, F. [3 ]
Bracarda, S. [1 ]
Escudier, B. [2 ]
Albiges, L. [2 ]
机构：
[1] Azienda Osped Santa Maria, Med & Translat Oncol, Terni, Italy
[2] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.800
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
728P
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [1] Efficacy of first-line immune checkpoint inhibitors in patients with sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).
    Bakouny, Ziad
    Abou Alaiwi, Sarah
    Nassar, Amin
    Steinharter, John A.
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Harshman, Lauren Christine
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [2] A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
    Elias, Roy
    Levonyak, Nicholas
    Christie, Alana
    Bowman, Isaac Alexander
    Kapur, Payal
    Hannan, Raquibul
    Hammers, Hans J.
    Brugarolas, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC)
    Araujo, Daniel Vilarim
    Malone, Eoghan Ruadh
    Sacher, Adrian G.
    Fallah-Rad, Nazanin
    Sridhar, Srikala S.
    Hansen, Aaron Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features
    Fontes-Sousa, Mario
    Calvo, Emiliano
    [J]. CANCER TREATMENT REVIEWS, 2022, 105
  • [5] Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Gide, Tuba N.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1260 - 1270
  • [6] Effectiveness of first-line immune checkpoint inhibitors (ICI) in advanced non-clear cell renal cell carcinoma (ccRCC).
    Graham, Jeffrey
    Wells, Connor
    Dudani, Shaan
    Gan, Chun Loo
    Donskov, Frede
    Lee, Jae-Lyun
    Kollmannsberger, Christian K.
    Pal, Sumanta K.
    Beuselinck, Benoit
    Hansen, Aaron Richard
    North, Scott A.
    Bjarnason, Georg A.
    Agarwal, Neeraj
    Kanesvaran, Ravindran
    Wood, Lori
    Hotte, Sebastien J.
    McKay, Rana R.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [7] Axitinib versus sorafenib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Hutson, Thomas E.
    Gallardo, Jorge
    Lesovoy, Vladmir
    Al-Shukri, Salman
    Stus, Viktor
    Bair, A. H.
    Rosbrook, Brad
    Bycott, Paul W.
    Tarazi, Jamal Christo
    Kim, Sinil
    Vogelzang, Nicholas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [8] Novel risk stratification criteria of metastatic renal cell carcinoma (mRCC) patients (pts) treated with immune checkpoint inhibitors (ICI).
    Martini, Dylan J.
    Liu, Yuan
    Shabto, Julie M.
    Carthon, Bradley Curtis
    Russler, Greta
    Hitron, Elise
    Caulfield, Sarah
    Kissick, Haydn
    Harris, Wayne
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Impact of corticosteroid (CS) exposure on acquired resistance to immune checkpoint inhibitor (ICI) therapy in patients (pts) with metastatic renal cell carcinoma (mRCC): A single centre experience.
    Cheruvu, Sowmya
    Marandino, Laura
    Gutierrez, Ana
    Le, Ha Mo Linh
    Bravi, Carlo Andrea
    Rosero, Diana I.
    Hogan, Nalinie Joharatnam
    Mcmahon, David
    Cazzaniga, Walter
    Larkin, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [10] Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.
    Saad, Eddy
    Labaki, Chris
    Miron, Benjamin
    Park, Jihye
    Bakouny, Ziad
    Nassar, Amin
    Saliby, Renee Maria
    Semaan, Karl
    Eid, Marc
    Meli, Kevin
    Laimon, Yasmin Nabil
    Geynisman, Daniel M.
    Kokate, Rutika
    Braun, David A.
    Signoretti, Sabina
    Mcgregor, Bradley Alexander
    Plimack, Elizabeth R.
    Choueiri, Toni K.
    Van Allen, Eliezer Mendel
    Zibelman, Matthew R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
12345